Nuveen Select Tax-Free Income Portfolio
NYSE:NXPAsset Management - Income
+$0.04 today
- Market cap
- $892.30M
- Beta
- 0.34
- P/E (TTM)
- 30.6
- EPS (TTM)
- $0.47
- Dividend yield
- 4.47%
Volume 0.19M
Average 0.14M
NXP Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Nuveen Select Tax-Free Income PortfolioNYSE: NXP
Accounts Receivables · Q4 FY2024 · quarter ended Mar 2025
Accounts receivables outflow grows to $0
Q4 FY2024 accounts receivables was $0, compared with $0 a year earlier.
Context
- Accounts receivables amounted to 0.0% of revenue in FY2024, unchanged from a year earlier.
- Accounts receivables increased in 0 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2024
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 0 | — |
| FY2023 | 2024-03-31 | 0 | — |
| FY2022 | 2023-03-31 | 0 | — |
| FY2021 | 2022-03-31 | 0 | — |
| FY2020 | 2021-03-31 | 0 | — |
Accounts Receivables vs competitors
How NXP compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Accounts receivables amounts to 0.0% of revenue for NXP, versus a peer median of 3.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $183.28M USD | +7.7% | — | 10.7% | |
NCDLNuveen Churchill Direct Lending Corp. | LTM Mar 2026 | $22.66M USD | +238.9% | — | 14.4% |
| LTM Dec 2025 | $4.82M USD | -29.1% | -27.2% | 2.9% | |
| LTM Mar 2026 | R$4.51M BRL | -112.7% | — | 0.3% | |
| LTM Mar 2026 | $4.3M USD | +59.6% | +20.5% | 3.2% | |
| FY2025 | $2.29M USD | +2653.0% | -25.8% | 21.1% | |
| LTM Dec 2025 | $2M USD | -48.6% | +7.0% | 3.7% | |
| LTM Mar 2026 | $1.75M USD | -84.1% | +129.5% | 1.0% | |
| LTM Oct 2025 | $140.13K USD | — | -23.9% | 0.3% | |
| FY2024 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NXP) | — | -10.7% | -8.5% | 3.2% | |
Competitors are the stored peer set for NXP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Mar 2021 | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|---|
| Net Income | 18.51M | (44.13M) | (299.2K) | 31.4M | 9.54M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (18.51M) | 44.13M | 299.2K | (31.4M) | (9.54M) |
| Operating Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 880.11K | 349.59K | (1.19M) | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 |
Nuveen Select Tax-Free Income Portfolio
NYSE:NXP
Intrinsic Alpha fair value
Locked
Current Price
$14.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.